There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:Pages using duplicate arguments in template calls
Jump to navigation
Jump to search
Pages in category "Pages using duplicate arguments in template calls"
The following 200 pages are in this category, out of 2,258 total.
(previous page) (next page)M
- Mammillary body
- Mason-Pfizer monkey virus packaging signal
- Masson's Pine
- MCPA
- MDEA
- Medulla of ovary
- Medulloblastoma classification
- Medulloblastoma medical therapy
- Membrana granulosa
- Membranous labyrinth
- Menstrual cycle
- Mescaline detailed information
- Mesembrine (data page)
- Mesometrium
- Mesosalpinx
- Mesovarium
- Mesulergine
- Metformin detailed information
- Methionine (data page)
- Method of steepest descent
- Methoxyethane
- Methoxypropane
- Methylenedioxymethamphetamine detailed information
- MicC RNA
- MicF RNA
- Microbial fuel cell
- Microfluidics
- Microsporum
- Microvillous inclusion disease
- Military brace
- Mir-10 microRNA precursor family
- Mir-101 microRNA precursor family
- Mir-103/107 microRNA precursor
- Mir-124 microRNA precursor family
- Mir-129 microRNA precursor family
- Mir-130 microRNA precursor family
- Mir-133 microRNA precursor family
- Mir-135 microRNA precursor family
- Mir-148/mir-152 microRNA precursor family
- Mir-15 microRNA precursor family
- Mir-156 microRNA precursor
- Mir-16 microRNA precursor family
- Mir-160 microRNA precursor family
- Mir-166 microRNA precursor
- Mir-17 microRNA precursor family
- Mir-172 microRNA precursor family
- Mir-181 microRNA precursor
- Mir-19 microRNA precursor family
- Mir-192/215 microRNA precursor
- Mir-194 microRNA precursor family
- Mir-196 microRNA precursor family
- Mir-199 microRNA precursor
- Mir-2 microRNA precursor
- Mir-218 microRNA precursor family
- Mir-219 microRNA precursor family
- Mir-24 microRNA precursor family
- Mir-26 microRNA precursor family
- Mir-29 microRNA precursor
- Mir-30 microRNA precursor
- Mir-34 microRNA precursor family
- Mir-395 microRNA precursor family
- Mir-399 microRNA precursor family
- Mir-46/mir-47/mir-281 microRNA precursor family
- Mir-6 microRNA precursor
- Mir-7 microRNA precursor
- Mir-8/mir-141/mir-200 microRNA precursor family
- Mir-9/mir-79 microRNA precursor family
- Mir-92 microRNA precursor family
- Mir-BART1 microRNA precursor family
- Mir-BART2 microRNA precursor family
- Mir-BHRF1-1 microRNA precursor family
- Mir-BHRF1-2 microRNA precursor family
- Mir-BHRF1-3 microRNA precursor family
- Mirror box
- Mitochondrion
- Mnt IRES
- Molecular cloud
- Molsidomine
- Mons pubis
- Multiple chemical sensitivity
- Multiple organ dysfunction syndrome
- Myeloproliferative neoplasm laboratory findings
- Myeloproliferative neoplasm other diagnostic studies
- Myometrium
- Myotomy
N
- N-Acetyltalosaminuronic acid
- N-myc internal ribosome entry site (IRES)
- Nanos 3' UTR translation control element
- Nasal processes
- Nature
- Nazia sand box
- Neonatal intensive care unit
- Template:Neural tracts
- Nickel(II) chloride
- Nicorandil
- Nipple
- Nitrogen trichloride
- Nitrogen triiodide
- Nitroprusside
- Nitrous acid
- No-reflow phenomenon prevention
- Non small cell lung cancer medical therapy metastatic cancer
- Nootropic
- Nosocomial infection
- Nuclear RNase P
- Nucleus accumbens
O
- Obesity in India
- Obinutuzumab
- Obsessive-compulsive disorder medical therapy
- Obtaining venous and arterial access
- Octane
- Ocularist
- Oil shale
- Omeprazole
- Omoconazole
- Template:Operations and other procedures on the musculoskeletal system
- Opium
- Orange County Health Department
- Orbitofrontal cortex
- Orthomyxoviridae
- Osaka City University
- Otto Loewi
- Ovarian ligament
- Ovary
- Oxyfedrine
- Oxygen
- OxyS RNA
P
- P27 cis-regulatory element
- Palmar intercarpal ligaments
- Paracetamol detailed information
- Parahydroxyamphetamine
- Paramethoxyethylamphetamine
- Paramethoxymethamphetamine
- Parkinsonism differential diagnosis
- Paroöphoron
- PCI complications: peri procedure bleeding
- PCI complications: renal failure
- PCI in the patient at risk of bleeding
- PCI in the patient in cardiogenic shock
- PCI in The Patient With an Allergy to Contrast Agents
- PCI in The Patient with Impaired Renal Function
- PCI in the patient with in stent restenosis
- Pediatric intensive care unit
- Percutaneous coronary intervention anaphylactoid reactions
- Percutaneous coronary intervention aorto-ostial stenoses
- Percutaneous coronary intervention bifurcation lesions
- Percutaneous coronary intervention bivalirudin and argatoban
- Percutaneous coronary intervention bleeding risk
- Percutaneous coronary intervention calcified lesions
- Percutaneous coronary intervention cardiac rehabilitation
- Percutaneous coronary intervention Cardiogenic shock
- Percutaneous coronary intervention certification and maintenance of certification
- Percutaneous coronary intervention chronic kidney disease
- Percutaneous coronary intervention chronic total occlusions
- Percutaneous coronary intervention clopidogrel genetic testing
- Percutaneous coronary intervention contrast-induced acute kidney injury
- Percutaneous coronary intervention coronary angiography strategies in STEMI
- Percutaneous coronary intervention coronary atherectomy
- Percutaneous coronary intervention cutting balloon angioplasty
- Percutaneous coronary intervention delayed or elective PCI in patients with STEMI
- Percutaneous coronary intervention dual antiplatelet therapy compliance and stent thrombosis
- Percutaneous coronary intervention embolic protection devices
- Percutaneous coronary intervention enoxaparin
- Percutaneous coronary intervention exercise testing
- Percutaneous coronary intervention fondaparinux
- Percutaneous coronary intervention fractional flow reserve
- Percutaneous coronary intervention heart team approach to revascularization decisions
- Percutaneous coronary intervention hybrid coronary revascularization
- Percutaneous coronary intervention intravascular ultrasound
- Percutaneous coronary intervention laser angioplasty
- Percutaneous coronary intervention left main coronary artery disease
- Percutaneous coronary intervention no-reflow pharmacological therapies
- Percutaneous coronary intervention non-left main coronary artery disease
- Percutaneous coronary intervention operator and institutional competency and volume
- Percutaneous coronary intervention oral antiplatelet therapy
- Percutaneous coronary intervention percutaneous hemodynamic support devices
- Percutaneous coronary intervention peri-procedural myocardial infarction assessment
- Percutaneous coronary intervention platelet function testing
- Percutaneous coronary intervention post-procedural antiplatelet therapy
- Percutaneous coronary intervention proton pump inhibitors and anti-platelet therapy
- Percutaneous coronary intervention quality and performance
- Percutaneous coronary intervention restenosis
- Percutaneous coronary intervention revascularization before non-cardiac surgery
- Percutaneous coronary intervention role of onsite surgical backup
- Percutaneous coronary intervention saphenous vein grafts
- Percutaneous coronary intervention ST-elevation myocardial infarction (STEMI)
- Percutaneous coronary intervention statin treatment
- Percutaneous coronary intervention thrombectomy
- Percutaneous coronary intervention unfractionated heparin
- Percutaneous coronary intervention unstable angina / non-ST elevation myocardial infarction (UA/NSTEMI)
- Percutaneous coronary intervention unstable Angina/non-ST-elevation myocardial infarction
- Percutaneous coronary intervention use of parenteral anticoagulants during PCI
- Percutaneous coronary intervention vascular access
- Percutaneous coronary intervention vascular closure devices
- Perflenapent
- Perfluoroethanamine (data page)
- Perimetrium
- Perverse effects of vaccination
- Pestivirus internal ribosome entry site (IRES)
- Phantom limb
Media in category "Pages using duplicate arguments in template calls"
This category contains only the following file.
-
PBB Protein CYGB image.jpg 500 × 500; 53 KB